524768 Stock Overview A healthcare company, provides nutritional products in India and internationally. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Emmessar Biotech & Nutrition Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Emmessar Biotech & Nutrition Historical stock prices Current Share Price ₹44.99 52 Week High ₹64.00 52 Week Low ₹24.81 Beta 0.74 1 Month Change -0.53% 3 Month Change 16.61% 1 Year Change 72.38% 3 Year Change 50.72% 5 Year Change 316.57% Change since IPO 1,185.43%
Recent News & Updates
Second quarter 2025 earnings released: EPS: ₹0.56 (vs ₹0.39 in 2Q 2024) Nov 09
Investor sentiment improves as stock rises 27% Nov 05
Emmessar Biotech & Nutrition Limited to Report Q2, 2025 Results on Nov 07, 2024 Oct 25
Investor sentiment improves as stock rises 20% Oct 15
Emmessar Biotech & Nutrition Limited Announces Change in Directorate Sep 27
First quarter 2025 earnings released: EPS: ₹0.18 (vs ₹0.11 in 1Q 2024) Aug 15 See more updates
Second quarter 2025 earnings released: EPS: ₹0.56 (vs ₹0.39 in 2Q 2024) Nov 09
Investor sentiment improves as stock rises 27% Nov 05
Emmessar Biotech & Nutrition Limited to Report Q2, 2025 Results on Nov 07, 2024 Oct 25
Investor sentiment improves as stock rises 20% Oct 15
Emmessar Biotech & Nutrition Limited Announces Change in Directorate Sep 27
First quarter 2025 earnings released: EPS: ₹0.18 (vs ₹0.11 in 1Q 2024) Aug 15
Emmessar Biotech & Nutrition Limited, Annual General Meeting, Sep 27, 2024 Aug 14
Emmessar Biotech & Nutrition Limited to Report Q1, 2025 Results on Aug 14, 2024 Aug 07
New minor risk - Share price stability Jul 11
Investor sentiment improves as stock rises 20% Jul 11
Full year 2024 earnings released: EPS: ₹1.48 (vs ₹1.01 in FY 2023) Jun 04
Emmessar Biotech & Nutrition Limited to Report Fiscal Year 2024 Results on May 29, 2024 May 17
Investor sentiment improves as stock rises 18% Apr 03
Emmessar Biotech & Nutrition Limited Approves Appointment of Dinesh Kumar Deora as an Additional Independent Director (Non- Executive) Mar 22
Investor sentiment deteriorates as stock falls 17% Mar 15
Third quarter 2024 earnings released: EPS: ₹0.26 (vs ₹0.04 loss in 3Q 2023) Feb 04
Investor sentiment improves as stock rises 20% Jan 29
Emmessar Biotech & Nutrition Limited to Report Q3, 2024 Results on Feb 03, 2024 Jan 24
Second quarter 2024 earnings released: EPS: ₹0.39 (vs ₹0.27 in 2Q 2023) Dec 11
Emmessar Biotech & Nutrition Limited to Report Q2, 2024 Results on Dec 09, 2023 Nov 27
New minor risk - Profit margin trend Aug 23
Full year 2023 earnings released: EPS: ₹0.99 (vs ₹0.94 in FY 2022) Aug 18
Emmessar Biotech & Nutrition Limited Approves the Appointment of Srinivasa Raghavan Mathurakavi Ayyangar as Chairman Aug 13
Emmessar Biotech & Nutrition Limited, Annual General Meeting, Sep 29, 2023 Aug 11
New minor risk - Financial data availability Aug 07
Emmessar Biotech & Nutrition Limited to Report Q1, 2024 Results on Aug 10, 2023 Jul 12
New major risk - Share price stability Jun 17
Emmessar Biotech & Nutrition Limited to Report Q3, 2023 Results on Feb 04, 2023 Jan 10 Emmessar Biotech & Nutrition Limited Announces Resignation of Vijaykumar Raghunandan Prasad from Board of Directors
Investor sentiment improved over the past week Nov 28
Less than half of directors are independent Nov 16
Emmessar Biotech & Nutrition Limited Approves Appointment of Milind Sitaram Desai as Additional Independent Director Oct 22
Emmessar Biotech & Nutrition Limited to Report First Half, 2023 Results on Oct 20, 2022 Oct 21
Emmessar Biotech & Nutrition Limited Announces Resignation of Director Sep 07
Full year 2022 earnings released: EPS: ₹0.94 (vs ₹2.90 in FY 2021) Aug 26
Investor sentiment improved over the past week Aug 10
Emmessar Biotech & Nutrition Limited to Report Q1, 2023 Results on Aug 08, 2022 Jul 09
Emmessar Biotech & Nutrition Limited, Annual General Meeting, Aug 08, 2022 Jul 08
Investor sentiment deteriorated over the past week Jun 21
Investor sentiment deteriorated over the past week May 18
Less than half of directors are independent Apr 27
Investor sentiment deteriorated over the past week Apr 19
Investor sentiment improved over the past week Apr 04
Investor sentiment improved over the past week Mar 15
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 15
Emmessar Biotech & Nutrition Limited to Report Q3, 2022 Results on Feb 11, 2022 Feb 03
Second quarter 2022 earnings released: EPS ₹0.37 (vs ₹0.91 in 2Q 2021) Oct 22
First quarter 2022 earnings released: EPS ₹0.18 (vs ₹0.06 in 1Q 2021) Aug 02
Investor sentiment improved over the past week Jul 27
Investor sentiment improved over the past week Jul 09
Investor sentiment improved over the past week May 28
Full year 2021 earnings released: EPS ₹2.88 (vs ₹1.51 in FY 2020) May 24
Investor sentiment improved over the past week Apr 24
Investor sentiment deteriorated over the past week Mar 26
New 90-day low: ₹15.80 Mar 15
Investor sentiment improved over the past week Feb 13
Third quarter 2021 earnings released: EPS ₹0.90 (vs ₹0.48 in 3Q 2020) Feb 08 Emmessar Biotech & Nutrition Limited Appoints Jeyavel Balaiah Nadar as Executive Director
Emmessar Biotech & Nutrition Limited to Report Q3, 2021 Results on Feb 06, 2021 Jan 29
Market bids up stock over the past week Dec 02
Emmessar Biotech & Nutrition Limited Appoints Anantharama Sethumani Subramanian as Additional Independent Director with Effect from November 6, 2020 Nov 24
Market bids up stock over the past week Nov 18
New 90-day high: ₹17.73 Nov 18
Full year earnings released - EPS ₹1.51 Sep 11
New 90-day high - ₹14.70 Aug 05
Emmessar Biotech & Nutrition Limited to Report Q4, 2020 Results on Jun 30, 2020 Jun 28 Shareholder Returns 524768 IN Pharmaceuticals IN Market 7D 2.8% 0.8% -4.2% 1Y 72.4% 39.7% 19.1%
See full shareholder returns
Return vs Market: 524768 exceeded the Indian Market which returned 19.1% over the past year.
Price Volatility Is 524768's price volatile compared to industry and market? 524768 volatility 524768 Average Weekly Movement 13.6% Pharmaceuticals Industry Average Movement 6.0% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 524768's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524768's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company Emmessar Biotech & Nutrition Limited, a healthcare company, provides nutritional products in India and internationally. The company operates through Healthcare and Rent on Lease Land segments. It also offers CalmCream, a multi-functional skin cream; Calm Cream RESQ, a skin cream used for burns from sun, radiation, heat and chemicals; Cute-N-Comely, a cosmetic skin cream; MagiCream, a cream used for post-surgical scars; and Muscle Flex Gel, a gel used to relieve pain from aching muscles.
Show more Emmessar Biotech & Nutrition Limited Fundamentals Summary How do Emmessar Biotech & Nutrition's earnings and revenue compare to its market cap? 524768 fundamental statistics Market cap ₹224.77m Earnings (TTM ) ₹8.65m Revenue (TTM ) ₹22.92m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 524768 income statement (TTM ) Revenue ₹22.92m Cost of Revenue ₹3.11m Gross Profit ₹19.81m Other Expenses ₹11.16m Earnings ₹8.65m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 1.73 Gross Margin 86.43% Net Profit Margin 37.74% Debt/Equity Ratio 0%
How did 524768 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/21 22:39 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Emmessar Biotech & Nutrition Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
